BSE filing, NSE: ANANDRATHI. Summary written from the filing by ALFA Finder's alert engine.
Anand Rathi Wealth Ltd: key numbers
- Share price
- ₹2,276.90
- Market cap
- ₹37,806 Cr
- Revenue (annual)
- ₹1,149 Cr
- Net profit (annual)
- ₹395.9 Cr
- P/E (TTM)
- 83.2×Sector 19.8×
- Promoter holding
- 40.95%-0.42% QoQ
- FII holding
- 6.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anand Rathi Wealth Ltd
All →Anand Rathi Wealth Annual General Meeting
Anand Rathi Wealth seeks shareholder approval via postal ballot for material related party transactions with Aligned Investment Private Limited and amendments to its Memorandum of Association.
- Value
- ₹1,200 Cr
Anand Rathi Wealth Annual General Meeting
Anand Rathi Wealth Limited issued a postal ballot notice to seek shareholder approval for altering its Objects Clause and for material related party transactions.
Anand Rathi Wealth Earnings Call Transcript: Key Takeaways
Anand Rathi delivered consistent growth, beating PAT guidance despite market volatility. Management maintains a rigid pricing model with zero discounts for high-value clients.
- Call
- Guides 14% growth
Anand Rathi Wealth Dividend
Anand Rathi Wealth Limited declared an interim dividend of ₹4 per equity share. The record date for the dividend payment is 15-10-2026.
Anand Rathi Wealth Investor Presentation: Key Takeaways
Anand Rathi Wealth reported robust Q2FY27 performance with 16.1% revenue growth and 22.2% PAT growth, driven by increasing AUM and market share in equity mutual funds.
Anand Rathi Wealth Q2 FY27 Results: Net Profit ₹89.3 Cr, Down 10.6% YoY
Anand Rathi Wealth Ltd reported revenue from operations of ₹344 Cr (+15.7% YoY) and net profit of ₹89.3 Cr (-10.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹89.3 Cr · -10.6% YoY
Other regulatory approval announcements
All →City Union Bank Regulatory Approval
City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.
- Execution
- Three years from the date of taking charge
Lupin Regulatory Approval
Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.
Som Distilleries & Breweries Regulatory Approval
Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.
AGI Infra Regulatory Approval
Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.
- Execution
- Valid up to March 30, 2031
360 One Wam Regulatory Approval
360 ONE Distribution Services' IFSC branch, a subsidiary of 360 ONE WAM, received an IFSCA Certificate of Registration to act as broker dealer, clearing member, depository participant, research entity and distributor. This is a regulatory licence authorising new activities in the IFSC.
Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.